🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
RDY
$RDY
🔒 US EquitiesDr. Reddys Laboratories Limited
AVG HISTORICAL GAP
0.00%
MAX GAP RECORD
-4.26%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $RDY
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$RDY
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 23, 2026 Earnings Release 2026-10-23 (BEFORE OPEN (08:00)) |
+2.19%
|
| May 09, 2025 Earnings Release 2025-05-09 (BEFORE OPEN) |
+2.73%
|
| Jan 23, 2025 Earnings Release 2025-01-23 (BEFORE OPEN) |
-0.07%
|
| Nov 05, 2024 Earnings Release 2024-11-05 (BEFORE OPEN) |
+2.45%
|
| Jul 26, 2024 Earnings Release 2024-07-26 (BEFORE OPEN) |
+0.46%
|
| May 07, 2024 Earnings Release 2024-05-07 (BEFORE OPEN) |
-2.20%
|
| Jan 30, 2024 Earnings Release 2024-01-30 (BEFORE OPEN) |
+0.09%
|
| Oct 27, 2023 Earnings Release 2023-10-27 (UNDETERMINED) |
+0.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
1.8%
Bullish Gaps (3)
Bearish Gaps (3)
Neutral / Flat (3)
📖 Intelligence Summary
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment refers to the manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗